Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Quadriserv launches first real time stock loan market data platform

Tuesday, October 12, 2010
Opalesque Industry Update - Quadriserv, Inc. announced that it has expanded its AQS Market Data products and services to include industry wide access. This latest offering will facilitate broad distribution of real-time securities lending market data for equity, ETF, index, and ADR products traded on AQS, the world's largest centrally-cleared securities lending market.

"Expanded access to AQS Market Data Services' suite of products brings a new dimension of actionable, transparent market information to the securities lending industry," said Thomas Little, President, AQS Market Data Services. "This market innovation underscores our conviction that reliable, real-time, and publicly available data is an essential component in the growth of liquid, regulated electronic markets. Ensuring the integrity and accessibility of this new data is of paramount importance as we move together with our distribution partners and Members to bring the product to market.

"We are pleased that this data been received positively both by the traditional securities lending market as well as the equity and equity derivatives markets. This latter development further validates Quadriserv's long held belief that access to transparent and reliable data will, in turn, yield a more efficient securities lending marketplace with enhanced liquidity and pricing that grows the market."

Consistent with existing AQS market connectivity options, real-time AQS Market Data will be available through a wide variety of existing and new subscription channels, including analytics platforms, APIs and data feeds.

AQS Market Data is available at three subscription levels, including:

· Level I: Price/Rebate Rates
· Level II: Full Depth of Book
· Level III: Derived Data

(press release)

Corporate website: Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for